Clinical Outcomes of Repeated Intraventricular Transplantation of Autologous Bone Marrow Mesenchymal Stem Cells in Chronic Haemorrhagic Stroke. A One-Year Follow Up.
Asra Al Fauzi, Purwati Sumorejo, Nur Setiawan Suroto, Muhammad Arifin Parenrengi, Joni Wahyuhadi, Agus Turchan, Ferdiansyah Mahyudin, Heri Suroto, Fedik Abdul Rantam, Mochammad Hasan Machfoed, Abdul Hafid Bajamal, Christianto Benjamin Lumenta
{"title":"Clinical Outcomes of Repeated Intraventricular Transplantation of Autologous Bone Marrow Mesenchymal Stem Cells in Chronic Haemorrhagic Stroke. A One-Year Follow Up.","authors":"Asra Al Fauzi, Purwati Sumorejo, Nur Setiawan Suroto, Muhammad Arifin Parenrengi, Joni Wahyuhadi, Agus Turchan, Ferdiansyah Mahyudin, Heri Suroto, Fedik Abdul Rantam, Mochammad Hasan Machfoed, Abdul Hafid Bajamal, Christianto Benjamin Lumenta","doi":"10.2174/1874205X01711010074","DOIUrl":null,"url":null,"abstract":"<p><strong>Object: </strong>Stroke, one of the most devastating diseases, is a leading cause of death and disability throughout the world and is also associated with emotional and economic problems. The main goal of this study was to investigate the clinical outcome of the intraventricular transplantation of bone marrow mesenchymal stem cells (BM-MSCs) in post-haemorrhagic stroke patients.</p><p><strong>Method: </strong>This study was done consisting of eight patients with supratentorial haemorrhagic stroke, who had undergone 24 weeks of standard treatment of stroke with stable neurological deficits. All of the patients received stem cell transplantation intraventricularly using autologous BM-MSCs. Six months and Twelve months after stem cells treatment, the clinical outcomes were measured using the National Institute of Health Stroke Scale (NIHSS) and adverse effect also observed.</p><p><strong>Result: </strong>The results of this study showed improvement of NIHSS score values before and after the treatment in five patients. No adverse effects or complications were detected during the 1-year observation.</p><p><strong>Conclusion: </strong>Intraventricular transplantation of BM-MSCs has shown benefits in improving the functional status of post-haemorrhagic stroke patients with no adverse effect.</p>","PeriodicalId":513493,"journal":{"name":"The Open Neurology Journal","volume":"11 ","pages":"74-83"},"PeriodicalIF":0.0000,"publicationDate":"2017-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2174/1874205X01711010074","citationCount":"7","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Open Neurology Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1874205X01711010074","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2017/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 7
Abstract
Object: Stroke, one of the most devastating diseases, is a leading cause of death and disability throughout the world and is also associated with emotional and economic problems. The main goal of this study was to investigate the clinical outcome of the intraventricular transplantation of bone marrow mesenchymal stem cells (BM-MSCs) in post-haemorrhagic stroke patients.
Method: This study was done consisting of eight patients with supratentorial haemorrhagic stroke, who had undergone 24 weeks of standard treatment of stroke with stable neurological deficits. All of the patients received stem cell transplantation intraventricularly using autologous BM-MSCs. Six months and Twelve months after stem cells treatment, the clinical outcomes were measured using the National Institute of Health Stroke Scale (NIHSS) and adverse effect also observed.
Result: The results of this study showed improvement of NIHSS score values before and after the treatment in five patients. No adverse effects or complications were detected during the 1-year observation.
Conclusion: Intraventricular transplantation of BM-MSCs has shown benefits in improving the functional status of post-haemorrhagic stroke patients with no adverse effect.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
